AAAAAA

   
Results: 1-20 |
Results: 20
Cyclin D1 polymorphism and increased risk of colorectal cancer at young age
Authors: Kong, SM Wei, QY Amos, CI Lynch, PM Levin, B Zong, JH Frazier, ML
Citation: Sm. Kong et al., Cyclin D1 polymorphism and increased risk of colorectal cancer at young age, J NAT CANC, 93(14), 2001, pp. 1106-1108
COX-2 inhibition in clinical cancer prevention
Authors: Lynch, PM
Citation: Pm. Lynch, COX-2 inhibition in clinical cancer prevention, ONCOLOGY-NY, 15(3), 2001, pp. 21-26
Age-associated risk of cancer among individuals with N-acetyltransferase 2(NAT2) mutations and mutations in DNA mismatch repair genes
Authors: Frazier, ML O'Donnell, FT Kong, SM Gu, XJ Campos, I Luthra, R Lynch, PM Amos, CI
Citation: Ml. Frazier et al., Age-associated risk of cancer among individuals with N-acetyltransferase 2(NAT2) mutations and mutations in DNA mismatch repair genes, CANCER RES, 61(4), 2001, pp. 1269-1271
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction
Authors: Ajani, JA Komaki, R Putnam, JB Walsh, G Nesbitt, J Pisters, PW Lynch, PM Vaporciyan, A Smythe, R Lahoti, S Raijman, I Swisher, S Martin, FD Roth, JA
Citation: Ja. Ajani et al., A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction, CANCER, 92(2), 2001, pp. 279-286
Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors
Authors: Komaki, R Janjan, NA Ajani, JA Lynch, PM Fairweather, JS Raijman, I Blumenshein, GR Ho, L Pisters, PWT Feig, BW Walsh, GL Pazdur, R
Citation: R. Komaki et al., Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors, ONCOLOGY-NY, 14(12), 2000, pp. 34-37
A pharmacokinetic and tolerability evaluation of two continuous subcutaneous infusion systems compared to an oral controlled-release morphine
Authors: Lynch, PM Butler, J Huerta, D Tsals, I Davidson, D Hamm, S
Citation: Pm. Lynch et al., A pharmacokinetic and tolerability evaluation of two continuous subcutaneous infusion systems compared to an oral controlled-release morphine, J PAIN SYMP, 19(5), 2000, pp. 348-356
Current applications of genetic technology in predisposition testing and microsatellite instability assays
Authors: Frazier, ML Su, LK Amos, CI Lynch, PM
Citation: Ml. Frazier et al., Current applications of genetic technology in predisposition testing and microsatellite instability assays, J CL ONCOL, 18(21), 2000, pp. 70S-74S
Genomic rearrangements of the APC tumor-suppressor gene in familial adenomatous polyposis
Authors: Su, LK Steinbach, G Sawyer, JC Hindi, M Ward, PA Lynch, PM
Citation: Lk. Su et al., Genomic rearrangements of the APC tumor-suppressor gene in familial adenomatous polyposis, HUM GENET, 106(1), 2000, pp. 101-107
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
Authors: Steinbach, G Lynch, PM Phillips, RKS Wallace, MH Hawk, E Gordon, GB Wakabayashi, N Saunders, B Shen, Y Fujimura, T Su, LK Levin, B Godio, L Patterson, S Rodriguez-Bigas, MA Jester, SL King, KL Schumacher, M Abbruzzese, J DuBois, RN Hittelman, WN Zimmerman, S Sherman, JW Kelloff, G
Citation: G. Steinbach et al., The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis, N ENG J MED, 342(26), 2000, pp. 1946-1952
Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer
Authors: Kong, SM Amos, CI Luthra, R Lynch, PM Levin, B Frazier, ML
Citation: Sm. Kong et al., Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer, CANCER RES, 60(2), 2000, pp. 249-252
Inactivation of germline mutant APC alleles by attenuated somatic mutations: A molecular genetic mechanism for attenuated familial adenomatous polyposis
Authors: Su, LK Barnes, CJ Yao, WZ Qi, Y Lynch, PM Steinbach, G
Citation: Lk. Su et al., Inactivation of germline mutant APC alleles by attenuated somatic mutations: A molecular genetic mechanism for attenuated familial adenomatous polyposis, AM J HU GEN, 67(3), 2000, pp. 582-590
Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer
Authors: Frazier, ML Sinicrope, FA Amos, CI Cleary, KR Lynch, PM Levin, B Luthra, R
Citation: Ml. Frazier et al., Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer, ONCOL REP, 6(3), 1999, pp. 497-505
Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma
Authors: Ajani, JA Mansfield, PF Lynch, PM Pisters, PW Feig, B Dumas, P Evans, DB Raijman, I Hargraves, K Curley, S Ota, DM
Citation: Ja. Ajani et al., Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma, J CL ONCOL, 17(8), 1999, pp. 2403-2411
Tumor downstaging and sphincter preservation with preoperative chemoradiation ln locally advanced rectal cancer: The M. D. Anderson Cancer Center experience
Authors: Janjan, NA Khoo, VS Abbruzzese, J Pazdur, R Dubrow, R Cleary, KR Allen, PK Lynch, PM Glober, G Wolff, R Rich, TA Skibber, J
Citation: Na. Janjan et al., Tumor downstaging and sphincter preservation with preoperative chemoradiation ln locally advanced rectal cancer: The M. D. Anderson Cancer Center experience, INT J RAD O, 44(5), 1999, pp. 1027-1038
Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer
Authors: Janjan, NA Abbruzzese, J Pazdur, R Khoo, VS Cleary, K Dubrow, R Ajani, J Rich, TA Goswitz, MS Evetts, PA Allen, PK Lynch, PM Skibber, JM
Citation: Na. Janjan et al., Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer, RADIOTH ONC, 51(2), 1999, pp. 153-160
Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposiscolorectal cancers relative to sporadic cancers
Authors: Sinicrope, FA Lemoine, M Xi, LX Lynch, PM Cleary, FR Shen, Y Frazier, ML
Citation: Fa. Sinicrope et al., Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposiscolorectal cancers relative to sporadic cancers, GASTROENTY, 117(2), 1999, pp. 350-358
Negative genetic test result in familial adenomatous polyposis - Clinical screening implications - Invited editorial
Authors: Lynch, HT Lynch, PM
Citation: Ht. Lynch et Pm. Lynch, Negative genetic test result in familial adenomatous polyposis - Clinical screening implications - Invited editorial, DIS COL REC, 42(3), 1999, pp. 310-312
Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer
Authors: Lynch, PM
Citation: Pm. Lynch, Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer, CANCER, 86(8), 1999, pp. 1713-1719
Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal
Authors: Lynch, PM
Citation: Pm. Lynch, Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal, CANCER, 86(11), 1999, pp. 2533-2539
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue - An uncontrolled trial
Authors: Steinbach, G Ford, R Glober, G Sample, D Hagemeister, FB Lynch, PM McLaughlin, PW Rodriguez, MA Romaguera, JE Sarris, AH Younes, A Luthra, R Manning, JT Johnson, CM Lahoti, S Shen, Y Lee, JE Winn, RJ Genta, RM Graham, DY Cabanillas, FF
Citation: G. Steinbach et al., Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue - An uncontrolled trial, ANN INT MED, 131(2), 1999, pp. 88
Risultati: 1-20 |